Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.298NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.298NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.433NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.433NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.433NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.561NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.561NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.561NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.605NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.605NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.605NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.596NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.596NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.596NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
W.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
W.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.565NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.565NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.565NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.361NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.361NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.361NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.101NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.101NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.101NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.478NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.478NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.478NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.86NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.86NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.86NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.543NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.543NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.543NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.139NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.139NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.139NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.221NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used